Skip to main content

Hudson Bay Capital Management LP

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1393825 STAMFORD, CT

Position in SRPT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,086,500
+$2,428,900 QoQ
Shares Held
450,000
+73.1% QoQ
Ownership
0.426%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#44
of 323 holders
Holding Since
Mar 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SRPT Over Time

Shares Held

Position Value (USD)

Derivatives in SRPT

reported options exposure · as of Jun 30, 2026
CallValue
$359,400
CallShares
20,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Hudson Bay Capital Management LP holds $565,820,903 across 77 Biotechnology names. SRPT ranks #17 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SRPT

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $359,400 20,000
2026-06-30 $8,086,500 450,000
2026-03-31 $5,657,600 260,000
2026-03-31 $1,088,000 50,000
2025-12-31 $1,076,000 50,000
2025-12-31 $5,918,000 275,000
2025-09-30 $963,500 50,000
2025-09-30 $3,854,057 200,003
2025-06-30 $4,584,510 268,100
2025-06-30 $1,629,630 95,300
2025-06-30 $342,000 20,000
2025-03-31 $12,779,955 200,250
2024-12-31 $7,903,350 65,000
2024-09-30 $8,117,850 65,000
2024-06-30 $1,185,000 7,500
2023-12-31 $8,505,897 88,208
2023-09-30 $6,073,122 50,100
2023-09-30 $5,454,900 45,000
2022-12-31 $6,139,500 47,380
2022-09-30 $18,791,800 170,000
2022-06-30 $14,055,000 187,500
2022-03-31 $3,320,100 42,500
2021-06-30 $2,915,250 37,500
2021-03-31 $2,086,840 28,000